Discover FiteBac®

international scientists  •  scientific publications  •   clinical trials

Patents

Composition of matter patents maintained in U.S., Europe, China

U.S. patents granted – silsesquioxanes, elastomers, drug

Trademarks received U.S., Europe, China, India, and Brazil

K21 QAS DRUG

FDA recognition of NME (new molecular entity)
FDA Drug Master file K21 QAS DRUG

FDA NDA 128706 K21 QAS DRUG Topical Antimicrobial

FDA cleared medical devices

FDA Device Master file with K21 QAS

FDA Device Master file with K18 QAMS

n

Research

Searachable Database

List View

Grid View

i

Press Releases

FiteBac Presents in Germany at International Dental Show

U.S.-Based FiteBac Presents in Germany for First Time at International Dental Show, IDS2021, to Feature New Antimicrobial Additives for Dental Restorative MaterialsSummary: FiteBac will be a new, featured presenter at the world’s largest dental conference, IDS 2021,...

read more